Filter News
Area of Research
- (-) Neutron Science (11)
- Advanced Manufacturing (1)
- Biology and Environment (22)
- Clean Energy (30)
- Climate and Environmental Systems (1)
- Computational Engineering (1)
- Computer Science (2)
- Fusion and Fission (2)
- Isotopes (2)
- Materials (30)
- Materials for Computing (2)
- National Security (7)
- Nuclear Science and Technology (1)
- Quantum information Science (1)
- Supercomputing (26)
News Topics
- (-) Biomedical (4)
- (-) Environment (3)
- (-) Microscopy (1)
- (-) Quantum Science (4)
- 3-D Printing/Advanced Manufacturing (3)
- Artificial Intelligence (1)
- Big Data (1)
- Bioenergy (3)
- Biology (4)
- Biotechnology (1)
- Climate Change (1)
- Composites (1)
- Computer Science (6)
- Coronavirus (5)
- Cybersecurity (1)
- Decarbonization (1)
- Energy Storage (2)
- Frontier (1)
- Fusion (1)
- High-Performance Computing (1)
- Materials (6)
- Materials Science (13)
- Nanotechnology (6)
- National Security (1)
- Neutron Science (40)
- Nuclear Energy (1)
- Physics (7)
- Security (1)
- Space Exploration (1)
- Summit (4)
- Sustainable Energy (2)
- Transportation (2)
Media Contacts
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.